Canada’s Drug Agency Announces New 5-Year Strategic Plan
Read more about Canada’s Drug Agency Announces New 5-Year Strategic Plan
Now Recruiting Patient Partners for our Rare Disease Registry Request for Proposals Evaluation Panel
Read more about Now Recruiting Patient Partners for our Rare Disease Registry Request for Proposals Evaluation Panel
Evolving the Patient Group Input Process in Drug Reimbursement Reviews
Read more about Evolving the Patient Group Input Process in Drug Reimbursement Reviews
Featured Reports
Powering evidence-informed drug and health technology decisions for sustainable, world-class health care for all
We are experts at finding, interpreting, and assembling the best available information, and we know that evidence is the foundation of good decision-making.
A National Capital Region’s top employer
We are proud and excited to share that our organization has been named one of the National Capital Region's top employers for 2025.
Latest News
Now Recruiting Patient Partners for our Rare Disease Registry Request for Proposals Evaluation Panel
Upcoming Events
Webinar for Patient Groups: Evolving Patient Group Input in Drug Reimbursement Reviews
Information Session: Developing a Consensus-Based Assessment Framework for Genetic and Genomic Biomarkers in Cancer Care
Canada’s Drug Agency recognizes the traditional territories, rights, and diversity of all First Nations, Inuit, and Métis communities across Canada. Indigenous Peoples have been, and continue to be, excluded from and harmed by Canada’s health care systems. In the spirit of reconciliation, we are committed to addressing these inequities alongside Indigenous communities.